Market Analysis of Infectious Diseases

The market for diagnostics for infectious diseases is anticipated to grow at a CAGR of 7.2% from USD 28.1 billion in 2021 to USD 39.8 billion in 2026. The rise in early illness detection awareness, the shift in emphasis from centralised laboratories to distributed POC testing, the global prevalence of infectious diseases, the advent of COVID-19, and technological advancements are all contributing to the market's expansion. The frequency of infectious diseases in developed and emerging countries will fuel the market's expansion for infectious disease diagnostics. The detection and treatment of such ailments is the cause of the increased need for diagnostic testing for infectious diseases. These elements, along with the rising trend toward preventative treatment, are anticipated to raise demand for infectious illness during the projection period.

Related Conference of Infectious Diseases